Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma progressed after platinum-based therapy or platinum ineligible

Authors :: J. R. Infante
M. Agrawal
Andrea B. Apolo
K.-W. Lee
Kevin M. Chin
Michael S. Gordon
Manish R. Patel
John Allan Ellerton
Michael Schlichting
Luc Dirix
Source :: Annals of Oncology. 27:vi267
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Metastatic Urothelial Carcinoma
business.industry
Anti pd 1
030232 urology & nephrology
chemistry.chemical_element
Hematology
Avelumab
03 medical and health sciences
0302 clinical medicine
chemistry
030220 oncology & carcinogenesis
Internal medicine
medicine
In patient
business
Platinum
medicine.drug

Full Text Access

Tools